3 results match your criteria: "European Centre of Pharmaceutical Medicine (ECPM)[Affiliation]"
A large number of cardiovascular events occur in seemingly healthy individuals. Atherosclerosis imaging can improve the outcome and treatment regime of such subjects. We aim to assess the predictive value of atherosclerosis imaging beyond traditional risk calculators in subjects aged 40-65 years.
View Article and Find Full Text PDFPrev Med Rep
June 2017
BAD Gesundheitsvorsorge und Sicherheitstechnik GmbH, Bonn, Germany.
Preventive therapy in primary care is guided by risk thresholds for future cardiovascular events. We aimed to assess whether the sensitivity of various risk calculators for the detection of subclinical carotid atherosclerosis (TPA80) could be improved by lowering risk thresholds in younger age groups. We compared sensitivity, specificity, and discriminatory performance of SCORE, SCORE-HDL, PROCAM, AGLA, FRAM and PCE coronary risk calculators to detect total plaque area > 80 mm2 (TPA80), a coronary risk equivalent, in age groups 40-55, 56-65, 66-75 from Germany (DE, = 2942) and Switzerland (CH, = 2202) during the years 2002 to 2016.
View Article and Find Full Text PDFSwiss Med Wkly
February 2015
Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, Canada.
Principles: As a result of the relatively low sensitivity of coronary risk charts, such as the Swiss coronary risk calculator (Arbeitsgruppe Lipide und Atherosklerose, AGLA), for detecting subjects with future myocardial infarction, the performance of arterial age (aa) as a surrogate marker for chronological age (ca) was tested.
Methods: In a practice based sample, burden of carotid plaque was obtained with ultrasound, using total plaque area (TPA). In this derivation cohort, sex-specific 5-year groups of mean TPA were calculated in subjects aged between 35 and 79 years.